News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Xentria's XTMAB-16 Secures Orphan Drug Designation from European Medicines Agency as Initial Patient Enlists in Trial
Thursday, November 16, 2023Xentria Inc a clinicalstage biopharmaceutical company dedicated to addressing unmet clinical needs has revealed that the European Medicines Agency has granted Orphan Drug Designation to its primary candidate
Autifony and Jazz Pharmaceuticals Forge Exclusive Global License and Collaboration Accord for Two Ion Channel Targets in Neurological Disorders
Wednesday, November 15, 2023Autifony Therapeutics Limited a pioneer in developing innovative pharmaceutical treatments for rare central nervous system disorders and other serious brain diseases recently disclosed an exclusive global licensing agreement with Jazz Pharmaceuticals...
Ethris and Heqet Therapeutics Collaborate to Develop RNA-Based Therapeutic Solutions for Heart Attack and Heart Failure
Tuesday, November 14, 2023Ethris GmbH a leading biotechnology company specializing in nextgeneration RNA therapeutics and vaccines has entered into a collaboration agreement with Heqet Therapeutics a biotechnology
Ajinomoto Co., Inc. Finalizes Acquisition of Forge Biologics for $620 Million
Monday, November 13, 2023Ajinomoto Co Inc and Forge Biologics have officially entered into a definitive agreement for Ajinomoto Co to acquire Forge in an allcash transaction valued at million Forge a significant player in genetic medicines operates as a viral vector and pla...
Pacira Secures FDA Approval for Extended EXPAREL Label, Introducing Two Additional Nerve Block Indications
Saturday, November 11, 2023Pacira BioSciences Inc has received approval from the US Food and Drug Administration for its supplemental new drug application to expand the label of EXPAREL
Roche's Elecsys NfL Test Receives FDA Breakthrough Device Designation for Multiple Sclerosis Support
Friday, November 10, 2023Roche a pharmaceutical company has recently announced that its Elecsys Neurofilament Light Chain test for Multiple Sclerosis has received Breakthrough Device Designation from the US Food and Drug Administration
Trishula Therapeutics Initiates Phase 2 Study of TTX-030, an Anti-CD39 Antibody, for First-Line Metastatic Pancreatic Cancer Patients
Friday, November 10, 2023Trishula Therapeutics Inc a privately held biotechnology company in the clinical stage has announced the commencement of a Phase trial to assess the safety and effectiveness of TTX an innovative antiCD antibody
Araris Biotech AG and Taiho Pharmaceutical Collaborate to Advance ADCs With Araris' Unique Linker-conjugation Technology
Thursday, November 09, 2023Araris Biotech AG a Swiss company specializing in oncology has recently entered into a collaborative agreement with Taiho Pharmaceutical Co Ltd a Japanese pharmaceutical company focused on oncology research and development
Bit.bio Introduces Cell Therapy Pipeline, Highlighting Primary Candidate for Acute Liver Failure, and Expands Scientific Advisory Board with International Experts in Cell Therapy
Thursday, November 09, 2023Bitbio an innovative company in the field of cell coding for novel cures has disclosed its cell therapy pipeline and introduced the lead cell therapy candidate bbHEP scheduled to enter clinical development in
Kynexis Introduces Efforts to Advance Precision Therapies for Brain Disorders
Wednesday, November 08, 2023Kynexis a biotechnology company focused on precision therapeutics for brain diseases has launched today securing million in Series A financing This funding round was led by Forbion with participation from Ysios Capital
